From early indication prioritization to go-to-market positioning, Cade Group delivers evidence-backed strategies that move biotech assets from concept to commercial success.

Where strategy meets science.

We Think Like Scientists. We Act Like Strategists.

In drug development, every stage is a narrowing window, and once it closes, the opportunity to differentiate is gone.

Cade Group operates on a single guiding principle: commercial success is won early, through deliberate, research-driven positioning that defines an asset’s advantage before it reaches the market.

Inspired by Dr. John Cade’s groundbreaking work in psychiatric medicine in 1940s Australia.

What We Deliver

Indication Prioritization Analyses

Target Product Profiles

Medical Value Propositions

Clinical Development Plans

Voice of Customer

Venture Financing

Fractional Team Solutions

The difference between approval and adoption is positioning. Let’s talk about how we secure yours.